biotech · Major Depressive Disorder · Schizophrenia · NBIX
NEUROCRINE BIOSCIENCES
NEUROCRINE BIOSCIENCES INC
NEUROCRINE BIOSCIENCES clinical programs — 25 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 6027 Edgewood Bend Ct, San Diego, California 92130, US
- Founded
- 1992
- Employees
- 2,307
- Programs
- 79
- Drugs
- 28
- Patents
- 111
NEUROCRINE BIOSCIENCES projects
25 ClinicalTrials.gov programs sponsored by NEUROCRINE BIOSCIENCES.
NEUROCRINE BIOSCIENCES has 25 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Chronocort
NEUROCRINE BIOSCIENCES INC
Primary Adrenal Insufficiency
1 trial -
Crinecerfont
NEUROCRINE BIOSCIENCES INC
CAH - Congenital Adrenal Hyperplasia
1 trial -
Hydrocortisone Modified Release Capsules
NEUROCRINE BIOSCIENCES INC
Endocrine Disease
1 trial -
Luvadaxistat
NEUROCRINE BIOSCIENCES INC
Schizophrenia
2 trials -
NBI-1065890
NEUROCRINE BIOSCIENCES INC
Tardive Dyskinesia
1 trial -
NBI-1070770
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
1 trial -
NBI-1117568
NEUROCRINE BIOSCIENCES INC
Bipolar I Disorder
1 trial -
NBI-1117570
NEUROCRINE BIOSCIENCES INC
Schizophrenia
1 trial -
NBI-1117570-SCZ2035
NEUROCRINE BIOSCIENCES INC
Schizophrenia
1 trial -
NBI-5788
NEUROCRINE BIOSCIENCES INC
Multiple Sclerosis
1 trial -
NBI-74788
NEUROCRINE BIOSCIENCES INC
Congenital adrenal hyperplasia (CAH)
1 trial -
NBI-74788
NEUROCRINE BIOSCIENCES INC
CAH - Congenital Adrenal Hyperplasia
1 trial -
NBI-827104
NEUROCRINE BIOSCIENCES INC
Essential Tremor
1 trial -
NBI-827104
NEUROCRINE BIOSCIENCES INC
Epileptic Encephalopathy
2 trials -
NBI-921352
NEUROCRINE BIOSCIENCES INC
Focal Onset Seizure
2 trials -
NBI-921352
NEUROCRINE BIOSCIENCES INC
SCN8A Developmental and Epileptic Encephalopathy Syndrome
2 trials -
NBI-98854
NEUROCRINE BIOSCIENCES INC
Tourette Syndrome
4 trials -
Placebo
NEUROCRINE BIOSCIENCES INC
Anhedonia
1 trial -
Placebo
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
1 trial -
TAK-041
NEUROCRINE BIOSCIENCES INC
Stable Schizophrenia
1 trial -
TAK-831
NEUROCRINE BIOSCIENCES INC
Friedreich Ataxia
1 trial -
Valbenazine
NEUROCRINE BIOSCIENCES INC
Obsessive-Compulsive Disorder
1 trial -
Valbenazine
NEUROCRINE BIOSCIENCES INC
Tourette Syndrome
4 trials -
Valbenazine Oral Capsule
NEUROCRINE BIOSCIENCES INC
Trichotillomania (Hair-Pulling Disorder)
1 trial -
interleukin-4 PE38KDEL cytotoxin
NEUROCRINE BIOSCIENCES INC
Brain and Central Nervous System Tumors
1 trial
Frequently asked questions
How many clinical projects does NEUROCRINE BIOSCIENCES have?
25 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.